{"id":"pyrimethamine-sulfadiazine","safety":{"commonSideEffects":[{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Bone marrow suppression"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Crystalluria"},{"rate":null,"effect":"Hepatotoxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Pyrimethamine inhibits dihydrofolate reductase in parasites, while sulfadiazine inhibits bacterial folate synthesis by blocking dihydropteroate synthase. Together, they create a dual blockade of the folate pathway, making them particularly effective against Toxoplasma gondii and other intracellular pathogens. This combination is the standard treatment for toxoplasmosis, especially in immunocompromised patients.","oneSentence":"Pyrimethamine and sulfadiazine work synergistically to inhibit folate metabolism in parasites and bacteria, blocking nucleotide synthesis and preventing microbial replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:52:05.037Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Toxoplasmosis, including cerebral toxoplasmosis in immunocompromised patients"},{"name":"Toxoplasma gondii infection prophylaxis and treatment"}]},"trialDetails":[{"nctId":"NCT06206746","phase":"NA","title":"The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System","status":"RECRUITING","sponsor":"May Health","startDate":"2024-03-25","conditions":"Polycystic Ovary Syndrome, Infertility, Female","enrollment":195},{"nctId":"NCT07360106","phase":"NA","title":"Efficacy of Symprove Probiotics in Coeliac Disease","status":"RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2026-01-29","conditions":"Coeliac Disease, Probiotic, Gluten","enrollment":24},{"nctId":"NCT04592445","phase":"NA","title":"Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF","status":"RECRUITING","sponsor":"Axon Therapies, Inc.","startDate":"2020-12-18","conditions":"Heart Failure With Preserved Ejection Fraction (HFpEF","enrollment":150},{"nctId":"NCT06533345","phase":"NA","title":"VCOM Pain Free Research Collaborative","status":"RECRUITING","sponsor":"Edward Via Virginia College of Osteopathic Medicine","startDate":"2024-08-30","conditions":"Chronic Pain","enrollment":120},{"nctId":"NCT04502316","phase":"","title":"Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)","status":"ACTIVE_NOT_RECRUITING","sponsor":"CVRx, Inc.","startDate":"2020-06-26","conditions":"Heart Failure","enrollment":5000},{"nctId":"NCT04687033","phase":"NA","title":"The Effect of The Ten-Session Dual-tDCS On Lower-Limb Performance in Sub- Acute and Chronic Stroke","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2021-01-01","conditions":"Stroke, Ischemic","enrollment":34},{"nctId":"NCT06814951","phase":"NA","title":"Acute Effect of the Thoraco-abdominal Rebalance Method on Diaphragmatic Function, Respiratory Discomfort, Pulmonary Complications and Hemodynamic Variables in Postoperative Cardiac Surgery Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto de Cardiologia do Rio Grande do Sul","startDate":"2024-09-01","conditions":"Respiratory Complications, Diaphragmatic Excursion, Pulmonary Spirometry","enrollment":8},{"nctId":"NCT06813521","phase":"NA","title":"Antidandruff Lotion Mediating Microbiome Rebalance","status":"RECRUITING","sponsor":"L'Oreal","startDate":"2024-09-01","conditions":"Dandruff","enrollment":120},{"nctId":"NCT06603168","phase":"NA","title":"Autonomic Recalibration","status":"COMPLETED","sponsor":"Edward Via Virginia College of Osteopathic Medicine","startDate":"2023-04-27","conditions":"Chronic Pain (Back / Neck), Autonomic Dysregulation","enrollment":20},{"nctId":"NCT03608150","phase":"NA","title":"Luminopia One Amblyopia Vision Improvement Study","status":"COMPLETED","sponsor":"Luminopia","startDate":"2019-01-16","conditions":"Amblyopia","enrollment":117},{"nctId":"NCT04040972","phase":"NA","title":"Rebalance: Compassion Focused Therapy in a Transdiagnostic Health Group","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2019-07-04","conditions":"Psychological Adjustment, Compassion, Chronic Disease","enrollment":6},{"nctId":"NCT05487937","phase":"","title":"Toleriane Ultra Reno in Allergic Subjects With Skin Intolerance to Their Usual Cosmetic","status":"COMPLETED","sponsor":"Cosmetique Active International","startDate":"2021-05-25","conditions":"Allergy","enrollment":109},{"nctId":"NCT00000794","phase":"PHASE2","title":"Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Toxoplasmosis, Cerebral, HIV Infections","enrollment":100},{"nctId":"NCT04287231","phase":"NA","title":"The Effect of The Five-Session Dual-tDCS On Lower-Limb Performance in Sub-Acute Stroke","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2019-08-19","conditions":"Stroke, Ischemic","enrollment":24},{"nctId":"NCT04584359","phase":"NA","title":"Effects of Osteopathic Manipulations and Muscle Training on the Myoelectric Activity of the Pelvic Floor","status":"COMPLETED","sponsor":"Giselle Notini Arcanjo","startDate":"2018-01-20","conditions":"Urinary Incontinence","enrollment":40},{"nctId":"NCT02726451","phase":"NA","title":"A Study to Examine the Effects of Cosmeceutical Therapy in Subjects Undergoing Full Facial Rejuvenation","status":"COMPLETED","sponsor":"DeNova Research","startDate":"2016-03","conditions":"Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid Fillers","enrollment":20},{"nctId":"NCT02328703","phase":"NA","title":"Reiki for the Management of Neuropathic Pain","status":"TERMINATED","sponsor":"Fort Belvoir Community Hospital","startDate":"2013-05","conditions":"Neuropathic Pain, Amputation, Traumatic","enrollment":2},{"nctId":"NCT01189448","phase":"PHASE3","title":"Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-11","conditions":"Congenital Toxoplasmosis","enrollment":149},{"nctId":"NCT01920490","phase":"NA","title":"Blame Rebalance fMRI Feedback Proof-of-concept","status":"COMPLETED","sponsor":"D'Or Institute for Research and Education","startDate":"2013-05","conditions":"Major Depressive Disorder","enrollment":32},{"nctId":"NCT01791426","phase":"NA","title":"A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye","status":"WITHDRAWN","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-05","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT00004317","phase":"PHASE4","title":"Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2000-07","conditions":"Toxoplasmosis","enrollment":600},{"nctId":"NCT00372294","phase":"PHASE3","title":"To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2005-07","conditions":"Chorioretinitis","enrollment":""},{"nctId":"NCT00367081","phase":"PHASE4","title":"Treatment of Cerebral Toxoplasmosis in HIV/AIDS","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2003-05","conditions":"Toxoplasmic Encephalitis, AIDS","enrollment":30},{"nctId":"NCT00001994","phase":"NA","title":"A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine","status":"COMPLETED","sponsor":"Glaxo Wellcome","startDate":"","conditions":"Toxoplasmosis, Cerebral, HIV Infections","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"BLASTOMYCOSIS"},{"count":4,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"SUPERINFECTION BACTERIAL"},{"count":2,"reaction":"DERMATITIS ALLERGIC"},{"count":2,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"},{"count":2,"reaction":"OFF LABEL USE"},{"count":2,"reaction":"STRONGYLOIDIASIS"},{"count":1,"reaction":"CHOLESTATIC LIVER INJURY"},{"count":1,"reaction":"DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS"},{"count":1,"reaction":"DYSPHAGIA"}],"_approvalHistory":[],"publicationCount":146,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Pyrimethamine = Malocide®","Sulfadiazine = Adiazine®"],"phase":"phase_3","status":"active","brandName":"Pyrimethamine/Sulfadiazine","genericName":"Pyrimethamine/Sulfadiazine","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pyrimethamine and sulfadiazine work synergistically to inhibit folate metabolism in parasites and bacteria, blocking nucleotide synthesis and preventing microbial replication. Used for Toxoplasmosis, including cerebral toxoplasmosis in immunocompromised patients, Toxoplasma gondii infection prophylaxis and treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}